| Serial Number | 79366379 |
| Word Mark | LIPOFLUIDICS |
| Filing Date | Monday, February 27, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 25, 2024 |
| Registration Number | 7423998 |
| Registration Date | Tuesday, June 25, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 9, 2024 |
| Goods and Services | Custom manufacture of goods in the nature of complementary medicines, traditional medicines, dietary supplements, nutritional supplements and medicinal herbal supplements; assembly of customized materials in the nature of complementary medicines, traditional medicines, dietary supplements, nutritional supplements and medicinal herbal supplements for others; medicinal materials treatment and processing; complementary medicines materials treatment and processing; material and product, namely, complementary medicines, traditional medicines, dietary supplements, nutritional supplements and medicinal herbal supplements processing services; chemistry reagent processing; treatment of materials in the nature of complementary medicines, traditional medicines, dietary supplements and medicinal herbal supplements; pharmaceutical filtration services being pharmaceutical processing services; processing of biopharmaceutical materials for others; custom fabricating, making or manufacturing of goods or materials, namely, manufacture of complementary medicines, traditional medicines, dietary supplements and medicinal herbal supplements for others; advisory, consultancy and information services in respect of all of the aforementioned services |
| Goods and Services | Complementary medicines including liposomal nutrients, namely, dietary supplements, nutritional supplements and vitamin supplements; dietary supplements; dietetic food supplements adapted for medical purposes; enzyme dietary supplements; food supplements being dietary supplements; food supplements for medical purposes; medicinal herbal preparations; herbal dietary supplements; vitamins; minerals being mineral supplements; medicated preparations for use as supplements for food; mineral food supplements; mineral preparations for use as dietary supplements to drinking water; nutritional supplements; protein dietary supplements; protein supplements for humans; supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; pharmaceutical preparations in the nature of dietary supplements, nutritional supplements and medicinal herbal supplements for health care; probiotics, namely, probiotic supplements; nutritional, medicinal and naturopathic preparations, and adjuvants for the aforementioned goods, namely, dietary supplements, nutritional supplements, food supplements being dietary supplementsand medicinal herbal supplements; amino acids for nutritional purposes; pharmaceutical products derived from natural sources, namely, dietary supplements, nutritional supplements, food supplements being dietary supplementsand medicinal herbal supplements; edible fish oil for medical purposes; evening primrose oil for medical use; esters of fatty acids for use as pharmaceutical preparations, namely, dietary supplements, nutritional supplements and food supplements being dietary supplementscontaining esters of fatty acids |
| Pseudo Mark | LIP FLUIDICS |
| Goods and Services | Liposomes for non-medical use, namely, industrial chemicals in the nature of liposome encapsulated molecules and vitamins for use in the manufacture of pharmaceutical products and complementary medicines; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacture of pharmaceuticals; mineral preparations for use in manufacturing, namely, mineral acids, minerals being sodium chloride, sodium carbonate and sodium sulfate, potassium being potassium citrate, potassium chloride, potassium phosphate, potassium aspartate, potassium bicarbonate and potassium gluconate, calcium being calcium carbonate and calcium citrate, and magnesium being magnesium aspartate, magnesium citrate, magnesium oxide, magnesium chloride, magnesium lactate, magnesium malate, magnesium taurate, magnesium L-threonate, magnesium sulfate, magnesium glycinate and magnesium orotate and trace elements being iron being ferrous sulfate, ferrous gluconate, ferric citrate, and ferric sulfate, copper being cupric oxide, cupric sulfate, copper gluconate, and copper amino acid chelates, zinc being zinc picolinate, zinc citrate, zinc acetate, zinc glycerate, and zinc monomethionine, selenium, iodine, chromium being chromium picolinate, chromium nicotinate, chromium polynicotinate, chromium chloride, and chromium histidinat, manganese being manganese sulfate, manganese gluconate and manganese chelate, and molybdenum being molybdenum chloride, sodium molybdate, molybdenum glycinate, and molybdenum amino acid chelate; chemical products and chemical substances, namely, chemical additives, for use in the manufacture of medicinal and pharmaceutical preparations and substances; enzymes for scientific purposes; fats and sugars being chemical substances for medicine manufacture, namely, lipids, phospholipids, carbohydrates, carbohydrate conjugates and industrial purpose sugar alcohols for use in the manufacture of medicines |
| Goods and Services | Research and development services in respect of complementary medicines and nanoparticle delivery systems; research services in the field of natural health; product development services in respect of complementary medicines; technical research in the field of complementary medicines studies; research and development of new products for others; science laboratory services; scientific research; quality control of complementary medicines services; quality testing services; quality assessment services, namely, product quality testing services in respect of complementary medicines and traditional medicines; chemical analysis and research services; bacteriological research services; clinical trials; medical research services; complementary medicine research, testing and development services; packaging design; technological services, namely, scientific research in respect of complementary medicines, dietary supplements, medicinal herbal supplements and nanoparticle delivery systems; industrial analysis and research services in the field of complementary medicines, traditional medicines and nanoparticle delivery systems; research and development in the field of therapeutics; research, development, scientific analysis and quality, safety and efficacy evaluation services in connection with biotechnology, microorganisms, pharmaceuticals, medicine, microbiome, biochemistry, probiotics, prebiotics, nutritional supplements; dietary supplements and nutraceutical supplements; advisory, consultancy and information services in respect of all of the aforementioned services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 3, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 3, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Spectrumceuticals Pty Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Party Name | Spectrumceuticals Pty Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Party Name | Spectrumceuticals Pty Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Event Date | Event Description |
| Thursday, March 30, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, April 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 7, 2023 | APPLICATION FILING RECEIPT MAILED |
| Sunday, October 1, 2023 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, October 31, 2023 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Tuesday, November 28, 2023 | ASSIGNED TO EXAMINER |
| Friday, December 1, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, December 2, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 18, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, January 18, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, February 6, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, February 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 21, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 21, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 4, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 4, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 4, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, March 27, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, March 27, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, April 9, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 16, 2024 | NOTIFICATION PROCESSED BY IB |
| Monday, March 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 25, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 25, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, September 25, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |